Rezultati - Lill‐Tove Busund
- Showing 1 - 20 results of 36
- Go to Next Page
-
1
-
2
-
3
-
4
Combination of low vascular endothelial growth factor A (VEGF‐A)/VEGF receptor 2 expression and high lymphocyte infiltration is a strong and independent favorable prognostic factor... od Tom Dønnem, Khalid Al‐Shibli, Sigve Andersen, Samer Al‐Saad, Lill‐Tove Busund, Roy M. Bremnes
Izdano 2010Artigo -
5
-
6
-
7
Overexpression of the HIF Hydroxylases PHD1, PHD2, PHD3 and FIH Are Individually and Collectively Unfavorable Prognosticators for NSCLC Survival od Sigve Andersen, Tom Dønnem, Helge Stenvold, Samer Al‐Saad, Khalid A. Alshibli, Lill‐Tove Busund, Roy M. Bremnes
Izdano 2011Artigo -
8
High expression of PDGFR-β in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence od Yngve Nordby, Elin Richardsen, Mehrdad Rakaee, Nora Ness, Tom Dønnem, Hiten Patel, Lill‐Tove Busund, Roy M. Bremnes, Sigve Andersen
Izdano 2017Artigo -
9
CD4/CD8 co-expression shows independent prognostic impact in resected non-small cell lung cancer patients treated with adjuvant radiotherapy od Sigurd M. Hald, Roy M. Bremnes, Khalid Al‐Shibli, Samer Al‐Saad, Sigve Andersen, Helge Stenvold, Lill‐Tove Busund, Tom Dønnem
Izdano 2013Artigo -
10
-
11
-
12
The Role of Tumor Stroma in Cancer Progression and Prognosis: Emphasis on Carcinoma-Associated Fibroblasts and Non-small Cell Lung Cancer od Roy M. Bremnes, Tom Dønnem, Samer Al‐Saad, Khalid Al‐Shibli, Sigve Andersen, Rafael Sirera, Carlos Camps, Inigo Marinez, Lill‐Tove Busund
Izdano 2010Revisão -
13
The Role of Tumor-Infiltrating Immune Cells and Chronic Inflammation at the Tumor Site on Cancer Development, Progression, and Prognosis: Emphasis on Non-small Cell Lung Cancer od Roy M. Bremnes, Khalid Al‐Shibli, Tom Dønnem, Rafael Sirera, Samer Al‐Saad, Sigve Andersen, Helge Stenvold, Carlos Camps, Lill‐Tove Busund
Izdano 2010Revisão -
14
Inverse Prognostic Impact of Angiogenic Marker Expression in Tumor Cells versus Stromal Cells in Non–Small Cell Lung Cancer od Tom Dønnem, Samer Al‐Saad, Khalid Al‐Shibli, Marit Pedersen Delghandi, Magnus Persson, Marit N. Nilsen, Lill‐Tove Busund, Roy M. Bremnes
Izdano 2007Artigo -
15
Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancer od Thomas K. Kilvaer, Mehrdad Rakaee, Turid Hellevik, Arne Östman, Carina Strell, Roy M. Bremnes, Lill‐Tove Busund, Tom Dønnem, Iñigo Martínez-Zubiaurre
Izdano 2018Artigo -
16
Changes in the Secretory Profile of NSCLC-Associated Fibroblasts after Ablative Radiotherapy: Potential Impact on Angiogenesis and Tumor Growth od Turid Hellevik, Ingvild Pettersen, Vivian Berg, Jack‐Ansgar Bruun, Kristian Bartnes, Lill‐Tove Busund, Anthony J. Chalmers, Roy M. Bremnes, Iñigo Martínez-Zubiaurre
Izdano 2013Artigo -
17
Cancer Associated Fibroblasts in Stage I-IIIA NSCLC: Prognostic Impact and Their Correlations with Tumor Molecular Markers od Thomas K. Kilvaer, Mehrdad Rakaee, Turid Hellevik, Samer Al‐Saad, Erna‐Elise Paulsen, Roy M. Bremnes, Lill‐Tove Busund, Tom Dønnem, Iñigo Martínez
Izdano 2015Artigo -
18
-
19
CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases od Erna‐Elise Paulsen, Thomas K. Kilvaer, Mehrdad Rakaee, Elin Richardsen, Sigurd M. Hald, Sigve Andersen, Lill‐Tove Busund, Roy M. Bremnes, Tom Dønnem
Izdano 2017Artigo -
20
High Progesterone Receptor Expression in Prostate Cancer Is Associated with Clinical Failure od Thea Grindstad, Sigve Andersen, Samer Al‐Saad, Tom Dønnem, Yury Kiselev, Christian Melbø‐Jørgensen, Kaja Skjefstad, Lill‐Tove Busund, Roy M. Bremnes, Elin Richardsen
Izdano 2015Artigo
Iskalna orodja:
Sorodne teme
Medicine
Internal medicine
Cancer
Oncology
Pathology
Cancer research
Immunohistochemistry
Biology
Tissue microarray
Lung cancer
Stromal cell
Immunology
Immune system
Gene
Multivariate analysis
Univariate analysis
CD8
Paleontology
Prostate cancer
Stage (stratigraphy)
Angiogenesis
Biochemistry
Lymph node
Prostate
microRNA
Confidence interval
Genetics
Hazard ratio
Metastasis
Prostatectomy